Trial Profile
A retrospective study investigating efficacy of Dabigatran-etexilate in prevention of secondary stroke.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record